Guest guest Posted August 3, 2005 Report Share Posted August 3, 2005 EuroLyme/message/30607 is a summary of what I've been looking into lately re efflux as a determinant in naturally-abx-resistant infections (including some concepts Matt pointed out). And of the severe theoretic problems this theory presents, tho on the whole it remains rather attractive to my addled little brain. PMID 15914491, beginning on page 33, contains some fascinating clues re what I am focusing on right now, which is possible justifications for the existence of extremely robust nonspecific efflux in only some bacteria, and only in certain situations (for instance, Bb in vivo vs in vitro). Specially interesting is the ref to PMID 11158756 in which hi-efflux pseudomonads were selected during *untreated* rat infection. This excites me even tho the phenomenon seen here is probably not remotely as robust as what would be required for an analogous model of eg poor treatability of borreliosis despite the ease of killing Bb in vitro. Perhaps host CAMP could have a role in such selection. If anyone has any ideas on this, lets jam dude. Ultimately if this is in fact actually whats going on (maybe / maybe not), it might be possible to advance treatment of this (probable/apparant) class of diseases by using drugs to target efflux pumps (about a billion years from now). And there may be some real difficulties there. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.